// App-Quantinova.ai

: Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK

Researchers

Presenter

  • Hannah Whittaker

Principal Investigators

  • Annalisa Rubino

  • Hana Müllerová

  • Tamsin Morris

  • Precil Varghese

  • Yang Xu

  • Enrico De Nigris

  • Jennifer K Quint

Medical Centers

  • Astra Zeneca, Cambridge, United Kingdom

  • AstraZeneca, Gaithersberg, MD, United States,

  • Imperial College, London, United Kingdom

  • AstraZeneca, Royston, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved